Luveniq Approval Status
FDA Approved: No
Brand name: Luveniq
Generic name: voclosporin
Company: Aurinia Pharmaceuticals Inc.
Treatment for: Uveitis
Luveniq (voclosporin) is a next-generation calcineurin inhibitor intended for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.
Development Status and FDA Approval Process for Luveniq
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.